BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/4/2025 6:59:26 AM | Browse: 34 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 103261
Country China
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients
Manuscript Source Unsolicited Manuscript
All Author List Zhi-Bin Wang, Bing Zhu, Ming-Ming Meng, Yi-Fan Wu, Yu Zhang, Dong-Ze Li, Hua Tian, Fu-Chuan Wang, Yi-Fan Lv, Qiu-Xia Ye and Fu-Quan Liu
Funding Agency and Grant Number
Funding Agency Grant Number
"14th Five-Year" Talent Training Program of Beijing Shijitan Hospital, Capital Medical University 2023LJRCLFQ
Corresponding Author Fu-Quan Liu, MD, Professor, Center for Minimally Invasive Treatment of Liver Diseases, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tieyi Road, Yangfangdian, Haidian district, Beijing 100080, China. lfuquan@aliyun.com
Key Words Liver cirrhosis; Portal hypertension; Transjugular intrahepatic portosystemic shunt; Hepatic encephalopathy; Liver failure; Carcinoma; Hepatocellular
Core Tip This study evaluates the impact of portal pressure gradient (PPG) reduction following transjugular intrahepatic portosystemic shunt (TIPS) on clinical outcomes in portal hypertension patients. Findings reveal that a significant PPG reduction (> 50%) post-TIPS is linked to decreased risks of rebleeding, shunt dysfunction, hepatocellular carcinoma, and mortality. However, it also raises the risk of hepatic encephalopathy and liver failure. Additionally, portal vein diameter influences the degree of PPG reduction. These insights highlight the need for personalized management strategies to optimize TIPS outcomes, balancing benefits and potential risks for improved patient prognosis.
Citation <p>Wang ZB, Zhu B, Meng MM, Wu YF, Zhang Y, Li DZ, Tian H, Wang FC, Lv YF, Ye QX, Liu FQ. Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients. <i>World J Hepatol</i> 2025; 17(3): 103261</p>
Received
2024-11-14 10:17
Peer-Review Started
2024-11-14 10:17
To Make the First Decision
Return for Revision
2025-01-22 16:20
Revised
2025-02-01 17:21
Second Decision
2025-03-04 02:33
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-03-04 06:59
Articles in Press
2025-03-04 06:59
Publication Fee Transferred
2025-02-05 12:16
Edit the Manuscript by Language Editor
2025-03-11 05:40
Typeset the Manuscript
2025-03-17 04:35
ISSN 1948-5182 (online)
Open Access Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com